RESUMO
OBJECTIVE: Inflammation and endothelial dysfunction are important venous changes in patients with chronic venous disease (CVD). The use of the venoactive drugs remains an important treatment modality for patients with CVD, reducing the severity of the CVD-related symptoms and swelling but also reducing inflammation and protecting endothelial cells. In this research, the effects of the serum obtained from patients with CVD before and after sulodexide treatment were evaluated for in vivo and in vitro inflammatory markers and endothelial cell function. METHODS: Inflammatory markers (IL-6, matrix metalloproteinase-9 [MMP-9], vascular cell adhesion molecule-1 [VCAM-1], and von Willebrand factor [vWF]) from the incompetent great saphenous veins (GSVs) and from the systemic venous circulation were studied in 10 patients with CVD (C2s) before and after 2 months of sulodexide (2 × 500 lipasemic units/d) therapy. Serum obtained from the vein blood before and after sulodexide treatment was evaluated for in vitro cultured human umbilical vein endothelial cell function. RESULTS: The serum collected from lower leg incompetent GSVs had significantly elevated levels of VCAM-1 (+29%, P < .001) compared with the serum from the systemic circulation. Endothelial cells exposed to the serum from the incompetent lower leg veins of the untreated CVD patients demonstrated higher stimulated synthesis of MMP-9 (+17%, P < .01), as well as increased markers of senescence (prolongation of population doubling time, ß-galactosidase activity, and expression of p21 and p53 genes). CVD serum-induced senescent endothelial cells had a higher expression of genes regulating IL-6, MMP-9, VCAM-1, and vWF synthesis. The overall proinflammatory effect on endothelial cells by the serum collected from the incompetent GSVs was stronger as compared with the serum from the systemic circulation. Serum collected from the veins after sulodexide treatment caused lower levels of endothelial cell inflammatory markers as well as respective gene expression than serum obtained at the beginning of the study (before sulodexide treatment). Sulodexide application also reduced the inflammatory secretory activity of the senescent endothelial cells. Sulodexide treatment resulted in the decrease of the majority of the studied inflammatory parameters in both lower limb incompetent vein and systemic blood. CONCLUSIONS: In patients with CVD, there are significant differences between circulating inflammatory markers analyzed from the lower leg incompetent GSV segments compared with the systemic circulation, indicating a higher inflammatory condition in CVD. Treatment with sulodexide reduces the proinflammatory and endothelial cell activation properties of the serum from patients with CVD. CLINICAL RELEVANCE: The study documented the significant proinflammatory human vascular endothelial cell activation when exposed to the serum collected from the varicose veins as compared with the serum from the systemic circulation in patients with chronic venous disease (CVD). The inflammatory marker expression, endothelial dysfunction, and endothelial cell senescence transformation can be successfully controlled and downregulated by patients' exposure to the glycosaminoglycan (sulodexide) treatment. Further studies are needed to confirm if glycosaminoglycan application can prevent further CVD clinical progression due to potential CVD-related pathological processes' modulation and their downregulation.
Assuntos
Glicosaminoglicanos , Células Endoteliais da Veia Umbilical Humana , Metaloproteinase 9 da Matriz , Molécula 1 de Adesão de Célula Vascular , Insuficiência Venosa , Humanos , Glicosaminoglicanos/sangue , Glicosaminoglicanos/uso terapêutico , Masculino , Feminino , Doença Crônica , Pessoa de Meia-Idade , Insuficiência Venosa/tratamento farmacológico , Insuficiência Venosa/sangue , Molécula 1 de Adesão de Célula Vascular/sangue , Células Endoteliais da Veia Umbilical Humana/efeitos dos fármacos , Células Endoteliais da Veia Umbilical Humana/metabolismo , Metaloproteinase 9 da Matriz/sangue , Biomarcadores/sangue , Resultado do Tratamento , Células Cultivadas , Veia Safena/efeitos dos fármacos , Idoso , Fator de von Willebrand/metabolismo , Mediadores da Inflamação/sangue , Adulto , Interleucina-6/sangueRESUMO
Concrete shrinkage is a phenomenon that results in a decrease of volume in the composite material during the curing period. The method for determining the effects of restrained shrinkage is described in Standard ASTM C 1581/C 1581M-09a. This article shows the calibration of measuring rings with respect to the theory of elasticity and the analysis of the relationship of steel ring deformation to high-performance concrete tensile stress as a function of time. Steel rings equipped with strain gauges are used for measurement of the strain during the compression of the samples. The strain is caused by the shrinkage of the concrete ring specimen that tightens around steel rings. The method allows registering the changes to the shrinkage process in time and evaluating the susceptibility of concrete to cracking. However, the standard does not focus on the details of the mechanical design of the test bench. To acquire accurate measurements, the test bench needs to be calibrated. Measurement errors may be caused by an improper, uneven installation of strain gauges, imprecise geometry of the steel measuring rings, or incorrect equipment settings. The calibration method makes it possible to determine the stress in a concrete sample leading to its cracking at specific deformation of the steel ring.
RESUMO
The physical metallurgical tests were performed on the test samples made of HR3C steel, taken from a section of a pipeline in the as-received condition and after approximately 26,000 h of service at 550 °C. In the as-received condition, the test material had austenitic microstructure with numerous large primary Z-phase precipitates inside the grains. The service of the test steel mainly contributed to the precipitation processes inside the grains and at the grain boundaries. After service, the following precipitates were identified in the microstructure of the test steel: Z-phase (NbCrN) and M23C6 carbides. The Z-phase precipitates were observed inside the grains, whereas M23C6 carbides - at the boundaries where they formed the so-called continuous grid. The service of the test steel contributed to the growth of the strength properties, determined both at room and elevated temperature (550, 600 °C), compared to the as-received condition. Moreover, the creep properties of HR3C steel after service were higher than those of the material in the as-received condition. The increase in the strength properties and creep resistance was connected with the growth of strengthening of the test steel by the precipitation of Z-phase and M23C6 carbides.